The most common practical error is not the schedule at all — it is losing track of which step you are on after a break, and then resuming at the top rather than re-approaching it. Not the answer, but possibly the question that gets there.
Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that.
Four-week escalation interval — I have the observation and I do not trust my interpretation of it, so I am posting the observation and holding the interpretation back.
Numbers, method and the conditions under which they were collected are below. Interpret them however they warrant.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
It is worth stating the boring hypothesis before the interesting one.
Post #2 put the caveat in the right place and I want to underline it.
A definition problem is doing most of the work in this four-week escalation interval discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small.
Practical experience of four-week escalation interval, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
My understanding of four-week escalation interval is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Where I part company with post #9, and it is a narrow parting.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
I have kept the units in throughout, for the obvious reason.
Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Filing a mild objection to the consensus on four-week escalation interval. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Four-week escalation interval was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Post #13 put the caveat in the right place and I want to underline it.
Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle.
Worth one more sentence than it usually gets.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
It is one reading of the data and not the only reasonable one.
The arithmetic in post #17 is right; the assumption feeding it is the part to check.
The reason four-week escalation interval is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Four-week escalation interval has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a weekly dosing schedule. Splitting it flattens the curve further but loses the convenience of once-weekly dosing. The trade-off is convenience versus a slightly flatter concentration curve.
I would put this at better than even and not much better.
That reframing is the whole thing. The facts I already had.
Worth stating the null on four-week escalation interval before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
On post #20 — agreed on the reasoning, with one qualification.
My position on four-week escalation interval is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Checked the four-week escalation interval claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Adding the measurement that post #26 says would settle it.
The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going faster. It is not an argument against going slower.
The general answer and the answer for your case may diverge here.
Post #25 describes the usual case. This is about the unusual one.
I read the earlier replies on four-week escalation interval twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.
That is a cleaner way of putting what I was circling around.
I read post #28 twice before replying, because I had assumed the opposite.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
A qualification I should have led with rather than closed on.